Literature DB >> 25031389

Gene of the month: Interleukin 6 (IL-6).

Parvin Ataie-Kachoie1, Mohammad H Pourgholami1, Des R Richardson2, David L Morris3.   

Abstract

The Interleukin 6 (IL-6) gene encodes the classic proinflammatory cytokine IL-6. It is also known as interferon-β2 (IFN-β2), B cell stimulatory factor-2 and hybridoma/plasmacytoma growth factor. IL-6 is a multifunctional cytokine with a central role in many physiological inflammatory and immunological processes. Due to its major role in initiation as well as resolving inflammation, deregulation of IL-6 is a mainstay of chronic inflammatory and autoimmune diseases. Additionally, IL-6 has been shown to be implicated in pathogenesis of many human malignancies. Thus, a better understanding of IL-6 and its role in various pathological conditions could enable the development of strategies to use it as a therapeutic target. This short review focuses on the structure, regulation and biological activities of IL-6. In addition we discuss the role of IL-6 in diseases with inflammatory background and cancer and also the therapeutic applications of anti-IL-6 agents. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Cancer Research; Cell Biology; Inflammation

Mesh:

Substances:

Year:  2014        PMID: 25031389     DOI: 10.1136/jclinpath-2014-202493

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  29 in total

1.  Interleukin-6 and interleukin-10 as acute kidney injury biomarkers in pediatric cardiac surgery.

Authors:  Jason H Greenberg; Richard Whitlock; William R Zhang; Heather R Thiessen-Philbrook; Michael Zappitelli; Prasad Devarajan; John Eikelboom; Peter A Kavsak; P J Devereaux; Colleen Shortt; Amit X Garg; Chirag R Parikh
Journal:  Pediatr Nephrol       Date:  2015-04-15       Impact factor: 3.714

Review 2.  Forging a signature of in vivo senescence.

Authors:  Norman E Sharpless; Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

Review 3.  Environmental immune disruptors, inflammation and cancer risk.

Authors:  Patricia A Thompson; Mahin Khatami; Carolyn J Baglole; Jun Sun; Shelley A Harris; Eun-Yi Moon; Fahd Al-Mulla; Rabeah Al-Temaimi; Dustin G Brown; Annamaria Colacci; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Roslida A Hamid; Leroy Lowe; Tiziana Guarnieri; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

4.  Characterization, promoter analysis and expression of the interleukin-6 gene in blunt snout bream, Megalobrama amblycephala.

Authors:  Xiaoqin Fu; Zhujin Ding; Jun Fan; Huanling Wang; Fengjuan Zhou; Lei Cui; Chen Boxiang; Weimin Wang; Hong Liu
Journal:  Fish Physiol Biochem       Date:  2016-05-28       Impact factor: 2.794

5.  STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.

Authors:  Mesias Pedroza; Thuy T Le; Katherine Lewis; Harry Karmouty-Quintana; Sarah To; Anuh T George; Michael R Blackburn; David J Tweardy; Sandeep K Agarwal
Journal:  FASEB J       Date:  2015-08-31       Impact factor: 5.191

6.  Improved Spatial Memory And Neuroinflammatory Profile Changes in Aged Rats Submitted to Photobiomodulation Therapy.

Authors:  Fabrízio Dos Santos Cardoso; Cristiane de Souza Oliveira Tavares; Bruno Henrique Silva Araujo; Fernanda Mansur; Rodrigo Álvaro Brandão Lopes-Martins; Sérgio Gomes da Silva
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

7.  Interleukin-6 suppression reduces tumour self-seeding by circulating tumour cells in a human osteosarcoma nude mouse model.

Authors:  Yinglong Zhang; Qiong Ma; Tao Liu; Guofeng Guan; Kailiang Zhang; Jiayan Chen; Nan Jia; Shiju Yan; Guanyin Chen; Shiluan Liu; Kuo Jiang; Yao Lu; Yanhua Wen; Haien Zhao; Yong Zhou; Qingyu Fan; Xiuchun Qiu
Journal:  Oncotarget       Date:  2016-01-05

8.  Sec13 Regulates Expression of Specific Immune Factors Involved in Inflammation In Vivo.

Authors:  Thais G Moreira; Liang Zhang; Lihi Shaulov; Amnon Harel; Sharon K Kuss; Jessica Williams; John Shelton; Bandarigoda Somatilaka; Joachim Seemann; Jue Yang; Ramanavelan Sakthivel; Daniel R Nussenzveig; Ana M C Faria; Beatriz M A Fontoura
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

9.  MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1.

Authors:  Chyi-Ying A Chen; Jeffrey T Chang; Yi-Fang Ho; Ann-Bin Shyu
Journal:  Nucleic Acids Res       Date:  2016-03-28       Impact factor: 16.971

Review 10.  Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer.

Authors:  Tae-Hwe Heo; Joseph Wahler; Nanjoo Suh
Journal:  Oncotarget       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.